KRAS and cancer: Given that glycosphingolipid biosynthesis reduces surface level of IFNGR1 and facilitates immune evasion in Kirsten rat sarcoma virus (KRAS)-driven cancer (46), we hypothesized that an analogous mechanism involving glycosphingolipid metabolism contributes to the suppression of IFNGR1 in the context of the RAC1A159V mutation.